Aurinia Pharmaceuticals
AUPH
AUPH
181 hedge funds and large institutions have $422M invested in Aurinia Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 51 increasing their positions, 46 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.64% more ownership
Funds ownership: 38.67% → 40.31% (+1.6%)
58% less call options, than puts
Call options by funds: $13.4M | Put options by funds: $31.7M
Holders
181
Holding in Top 10
1
Calls
$13.4M
Puts
$31.7M
Top Buyers
| 1 | +$27.6M | |
| 2 | +$3.32M | |
| 3 | +$2.99M | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$2.82M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.27M |
Top Sellers
| 1 | -$18.2M | |
| 2 | -$5.69M | |
| 3 | -$2.79M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.42M |
| 5 |
6CM
683 Capital Management
New York
|
-$2.28M |